S. Sugiyama et al. / Tetrahedron 67 (2011) 6654e6658
6657
washed with brine, dried over MgSO4, filtered, and concentrated in
vacuo. The residue was used for the next reaction without further
purification.
1424, 1330, 1275, 1161, 1097, 1048 cmꢁ1; HRMS (ESI-TOF); [MþH]þ
calcd for C24H33O5, 401.2328; found 401.2326.
To a solution of the crude cyanohydrin in CH2Cl2 (10.0 mL) were
added ethyl vinyl ether (1.64 mL, 17.1 mmol) and CSA (132 mg,
0.568 mmol) at 0 ꢀC under Ar. After being stirred at room tem-
perature for 1 h, the reaction mixture was poured into saturated
aqueous NaHCO3 and extracted with Et2O. The extract was washed
with brine, dried over MgSO4, filtered, and concentrated in vacuo.
The residue was purified by column chromatography on silica gel,
and eluted with 5% ethyl acetate in hexane to afford the protected
cyanohydrin 10 (1.78 g, 7.08 mmol, 83%) as a colorless oil (di-
astereomeric mixture).
4.1.6. The RAL analogue 13. To a solution of the cyclization pre-
cursor 18 (47.6 mg, 0.119 mmol) in CH2Cl2 (24.0 mL) was added
Grubbs II catalyst (10.0 mg, 0.0119 mmol) at room temperature
under Ar. After being stirred at the same temperature for 3 h, the
mixture was filtered and concentrated in vacuo. The residue was
purified by column chromatography on silica gel (20% in ethyl ac-
etate in hexane) to afford the RAL analogue 13 (39.8 mg,
0.115 mmol, 97%) as a white solid. Mp 117e118 ꢀC; 1H NMR
(400 MHz, CDCl3)
d
6.38 (s, 2H), 5.90 (s, 1H), 5.38 (dt, J¼15.5, 6.8 Hz,
2H), 5.30 (ddd, J¼15.5, 6.3, 5.8 Hz, 2H), 4.34 (t, J¼5.3 Hz, 2H), 3.81
(s, 3H), 3.79 (s, 3H), 3.56 (s, 2H), 2.41 (dt, J¼5.8, 5.3 Hz, 2H),
4.1.3. Aryl iodide 11. To a solution of the protected cyanohydrin 10
(98.9 mg, 0.393 mmol) in THF (5.00 mL) was added dropwise
LiN(TMS)2 (0.454 mL, 1.00 M in toluene, 0.454 mmol) at ꢁ78 ꢀC
under Ar. After being stirred at the same temperature for 30 min,
a solution of 1-(bromoethyl)-2-iodo-3,5-dimethoxybenzene (7)
(108 mg, 0.303 mmol) in THF (3.00 mL) was added to the reaction
mixture at ꢁ78 ꢀC. After being stirred at 0 ꢀC for 30 min, the mix-
ture was poured into Et2O and 1 M HCl, and extracted with Et2O.
The extract was washed with saturated aqueous NaHCO3 and brine,
dried over MgSO4, filtered, and concentrated in vacuo. The residue
was purified by column chromatography on silica gel, and eluted
with 25% Et2O in hexane to afford the aryl iodide 11 (133 mg,
0.252 mmol, 83%) as a colorless oil (diastereomeric mixture).
2.17e2.08 (m, 7H); 13C NMR (67.8 MHz, CDCl3)
d 197.2, 168.2, 161.4,
158.2, 157.6, 134.9, 131.8, 128.0, 123.9, 117.6, 105.7, 97.7, 64.2, 55.9,
55.4, 48.7, 39.7, 31.6, 29.4, 19.8; FT-IR (solid) 2948, 1720, 1675, 1587,
1453, 1381, 1264, 1198, 1069, 961, 635 cmꢁ1; HRMS (ESI-TOF);
[MþH]þ calcd for C20H25O5, 345.1702; found 345.1704.
Acknowledgements
We thank Prof. Takayuki Doi (Tohoku University) for his fruitful
discussions.
Supplementary data
Supplementary data associated with this article can be found, in
clude MOL files and InChIKeys of the most important compounds
described in this article.
4.1.4. Ester 12. In a glass vessel, to a suspension of the aryl iodide 11
(283 mg, 0.535 mmol) and 3-butene-1-ol (8) (0.136 mL, 1.60 mmol)
in DMF (3.00 mL) were added PdCl2(PPh3)2 (18.7 mg, 26.6 mmol)
and DBU (0.160 mL, 1.07 mmol) under Ar. The vessel was placed in
an autoclave, which was purged with CO three times before ap-
plication of pressure (15 atm). After it was stirred at 100 ꢀC for 12 h,
the reaction mixture was poured into Et2O and saturated aqueous
NH4Cl, and extracted with Et2O. The extract was washed with
saturated aqueous NaHCO3 and brine, dried over MgSO4, filtered,
and concentrated in vacuo. The residue was purified by column
chromatography on silica gel, and eluted with 30% Et2O in hexane
to afford the ester 12 (163 mg, 0.326 mmol, 61%) as a colorless oil
(diastereomeric mixture).
References and notes
1. Delmotte, P.; Delmotte-Plaquee, J. Nature 1953, 171, 344.
2. Winssinger, N.; Barluenga, S. Chem. Commun. 2007, 22e36.
3. Hofmann, T.; Altmann, K. H. C. R. Chim. 2008, 11, 1318e1335.
4. Barluenga, S.; Dakas, P. Y.; Boulifa, M.; Moulin, E.; Winssinger, N. C. R. Chim.
2008, 11, 1306e1317.
5. Winssinger, N.; Fontaine, J. G.; Barluenga, S. Curr. Top. Med. Chem. 2009, 9,
1419e1435.
6. Jogireddy, R.; Dakas, P. Y.; Valot, G.; Barluenga, S.; Winssinger, N. Chem.dEur. J.
2009, 15, 11498e11506.
7. Chiba, K.; Du, H.; Eguchi, Y.; Fujita, M.; Goto, M.; Gusovsky, F.; Harmange, J. -C.;
Inoue, A.; Kawada, M.; Kawai, T.; Kawakami, Y.; Kimura, A.; Kotake, M.; Kuboi,
Y.; Matsushima, T.; Mizui, Y.; Muramoto, K.; Sakurai, H.; Shen, Y. -c.; Shirota, H.;
Spyvee, M.; Tanaka, I.; Wang, J.; Wood, R.; Yamamoto, S.; Yoneda, N. U.S.
2004224936, 2004.
8. Garbaccio, R. M.; Stachel, S. J.; Baeschlin, D. K.; Danishefsky, S. J. J. Am. Chem. Soc.
2001, 123, 10903e10908.
4.1.5. Cyclization precursor 18. To a solution of the protected cya-
nohydrin 12 (44.0 mg, 88.1 mmol) in THF (2.00 mL) was added 1 M
HCl (2.00 mL) at room temperature. After being stirred at the same
temperature for 3 h, the mixture was diluted with Et2O and
extracted with Et2O. The extract was washed with saturated
aqueous NaHCO3 and brine, dried over MgSO4, filtered, and con-
centrated in vacuo. The residue was used for the next reaction
without further purification.
To a solution of the residue in Et2O (2.00 mL) was added 1 M
NaOH (2.00 mL) at 0 ꢀC. After being stirred at room temperature for
3 h, the mixture was diluted with Et2O and extracted with Et2O. The
extract was washed with saturated aqueous NH4Cl (caution: HCN is
generated) and brine, dried over MgSO4, filtered, and concentrated
in vacuo. The residue was purified by column chromatography on
silica gel, and eluted with 15% ethyl acetate in hexane to afford the
9. Shinonaga, H.; Noguchi, T.; Ikeda, A.; Aoki, M.; Fujimoto, N.; Kawashima, A.
Biorg. Med. Chem. 2009, 17, 4622e4635.
10. Hofmann, T.; Altmarm, K. H. Synlett 2008, 1500e1504.
11. Navarro, I.; Basset, J. F.; Hebbe, S.; Major, S. M.; Werner, T.; Howsham, C.;
Brackow, J.; Barrett, A. G. M. J. Am. Chem. Soc. 2008, 130, 10293e10298.
12. Stevenson, D. E.; Hansen, R. P.; Loader, J. I.; Jensen, D. J.; Cooney, J. M.; Wilkins,
A. L.; Miles, C. O. J. Agric. Food Chem. 2008, 56, 4032e4038.
13. Baird, L. J.; Timmer, M. S. M.; Teesdale-Spittle, P. H.; Harvey, J. E. J. Org. Chem.
2009, 74, 2271e2277.
14. Barluenga, S.; Fontaine, J. G.; Wang, C. H.; Aouadi, K.; Chen, R. H.; Beebe, K.;
Neckers, L.; Winssinger, N. ChemBioChem 2009, 10, 2753e2759.
15. Dakas, P. Y.; Jogireddy, R.; Valot, G.; Barluenga, S.; Winssinger, N. Chem.dEur. J.
2009, 15, 11490e11497.
16. Day, J. E. H.; Blake, A. J.; Moody, C. J. Synlett 2009, 1567e1570.
17. Du, H.; Matsushima, T.; Spyvee, M.; Goto, M.; Shirota, H.; Gusovsky, F.; Chiba, K.;
Kotake, M.; Yoneda, N.; Eguchi, Y.; DiPietro, L.; Harmange, J. C.; Gilbert, S.; Li, X.
Y.; Davis, H.; Jiang, Y.; Zhang, Z.; Pelletier, R.; Wong, N.; Sakurai, H.; Yang, H.; Ito-
Igarashi, H.; Kimura, A.; Kuboi, Y.; Mizui, Y.; Tanaka, I.; Ikemori-Kawada, M.;
Kawakami, Y.; Inoue, A.; Kawai, T.; Kishi, Y.; Wang, Y. Bioorg. Med. Chem. Lett.
2009, 19, 6196e6199.
18. Wang, C. H.; Barluenga, S.; Koripelly, G. K.; Fontaine, J. G.; Chen, R. H.; Yu, J. C.;
Shen, X. D.; Chabala, J. C.; Heck, J. V.; Rubenstein, A.; Winssinger, N. Bioorg. Med.
Chem. Lett. 2009, 19, 3836e3840.
cyclization precursor 18 (31.7 mg, 79.2
m
mol) (31.7 mg, 79.2
m
mol, 2
steps 90%) as a colorless oil. 1H NMR (400 MHz, CDCl3)
d
6.38 (d,
J¼2.4 Hz, 1H), 6.32 (d, J¼2.4 Hz, 1H), 6.07 (s, 1H), 5.84 (ddt, J¼17.4,
10.1, 6.8 Hz, 1H), 5.13 (d, J¼17.4 Hz, 1H), 5.08e5.00 (m, 2H), 4.31 (t,
J¼6.8 Hz, 2H), 3.80 (s, 3H), 3.79 (s, 3H), 3.72 (s, 2H), 2.46 (dt, J¼6.8,
6.3 Hz, 2H), 2.13e2.11 (m, 7H), 1.67 (s, 3H), 1.58 (s, 3H); 13C NMR
(67.8 MHz, CDCl3)
d 196.8, 167.6, 161.6, 159.9, 158.8, 135.9, 134.2,
132.4, 123.0, 122.3, 117.0, 116.6, 107.1, 97.6, 64.1, 55.9, 55.4, 49.2, 41.3,
33.0, 26.1, 25.6, 19.5, 17.6; FT-IR (neat) 2925, 1723, 1685, 1605, 1457,
19. Zimmermann, T. J.; Niesen, F. H.; Pilka, E. S.; Knapp, S.; Oppermann, U.; Maier,
M. E. Biorg. Med. Chem. 2009, 17, 530e536.